Promentis Pharmaceuticals, Inc.

Promentis Pharmaceuticals, Inc.

Promentis Pharmaceuticals, Inc.

Overview
Date Founded

2007

Headquarters

826 North Plankinton Avenue,Suite 400,Milwaukee, WI 53203

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Medical Support Services
Biotechnology
Holding Companies

Company Description

Promentis Pharmaceuticals, Inc. operates as a pharmaceutical company that develops novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded in 2007 by David A. Baker and John Mantsch and is headquartered in Milwaukee, WI.

Executives & Employees

Co-Founder

Chairman & Chief Executive Officer

President

Chief Medical Officer

Senior Director & Head of Clinical Operations

Director of Research

Senior Vice President-Research & Development

Vice President of Finance

Board of Directors

Venture Partner at OrbiMed Advisors LLC

Venture Partner at OrbiMed Advisors LLC

Executive Partner at F-Prime Capital Partners

Partner at Aisling Capital

Managing Director at Black Horse Investments GmbH

President at Promentis Pharmaceuticals, Inc.

Paths to Promentis Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Promentis Pharmaceuticals, Inc.
Recent Transactions
Details Hidden

Promentis Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Promentis Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Promentis Pharmaceuticals, Inc. raised money in a private placement transaction

Advisors & Consultants
Publicist

Senior Account Executive at Tiberend Strategic Advisors, Inc.

Publicist

Vice President at Tiberend Strategic Advisors, Inc.

Investors
Details Hidden

Golden Angels Investors LLC operates as an investment company that engages in helping capital formation for entrepreneurs in the Midwest. The firm invests in early stage businesses and helping these businesses accelerate in the market. The company was founded by Timothy Keane in 2002 and is headquartered in Brookfield, WI.

Details Hidden

Aisling invests in life science companies developing biopharmaceutical products and creating businesses based on advanced life science technologies.

Details Hidden

Black Horse Investments GmbH provides investment services. The firm's investment operations focus on pharmaceutical businesses and property development activities. Its focus areas encompass asset management, project management, and business development and financing. The company is headquartered in Duesseldorf, Germany.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Promentis Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Promentis Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Promentis Pharmaceuticals, Inc..